US BANCORP \DE\ - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CUREVAC N V
ValueSharesWeighting
Q3 2023$21,214
-49.6%
3,106
-23.1%
0.00%
Q2 2023$42,066
+63.4%
4,037
+9.3%
0.00%
Q1 2023$25,740
+70.5%
3,693
+47.5%
0.00%
Q4 2022$15,099
+67.8%
2,504
+133.8%
0.00%
Q3 2022$9,000
-85.0%
1,071
-75.7%
0.00%
Q2 2022$60,000
-62.3%
4,404
-45.8%
0.00%
Q1 2022$159,000
-37.9%
8,123
+8.9%
0.00%
Q4 2021$256,000
-11.4%
7,458
+40.5%
0.00%
-100.0%
Q3 2021$289,0005,3080.00%
Other shareholders
CUREVAC N V shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,625,943$16,942,32613.48%
RA Capital Management 12,245,955$127,602,8512.41%
Avidity Partners Management LP 4,300,000$44,806,0001.56%
Camber Capital Management LP 1,462,500$15,2390.50%
Eversept Partners, LP 357,342$3,723,5040.31%
Ghisallo Capital Management LLC 100,000$1,042,0000.12%
PLATINUM INVESTMENT MANAGEMENT LTD 226,134$2,356,3160.08%
Green Alpha Advisors, LLC 11,492$119,7470.08%
Alyeska Investment Group, L.P. 899,423$9,371,9880.07%
Virtus ETF Advisers LLC 10,692$111,4110.07%
View complete list of CUREVAC N V shareholders